FDA Approves Aduhelm

FDA Grants Accelerated Approval for Aduhelm (aducanumab-avwa) for the Treatment of Alzheimer’s Disease CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Aduhelm™ (aducanumab-avwa) as the first and only Alzheimer’s disease treatment to address a […]

Read more

FDA Approves Myfembree

FDA Approves Myfembree as the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids BASEL, Switzerland and NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Myfembree (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg), […]

Read more

Injectafer (ferric carboxymaltose injection) Receives FDA Approval for Single Dose Option for the Treatment of Adult Patients with Iron Deficiency Anemia

BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer® (ferric carboxymaltose injection), an iron replacement product, for the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance to […]

Read more

FDA Approves Zynlonta

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma LAUSANNE, Switzerland–(BUSINESS WIRE) APRIL 23, 2021 — ADC Therapeutics SA (NYSE: ADCT) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynlonta (loncastuximab tesirine-lpyl) for the treatment of adult patients with relapsed or refractory (r/r) large B-cell lymphoma after two or more lines of […]

Read more

With GOP Back at Helm, Montana Renews Push to Sniff Out Welfare Fraud

Montana is considering becoming the latest state to intensify its hunt for welfare overpayments and fraud, a move expected to remove more than 1,500 enrollees from low-income health coverage at a time when the pandemic has left more people needing help. With Republicans now controlling both chambers of the Montana legislature and the governor’s office, a lawmaker is reviving an […]

Read more

Avomine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Avomine® Promethazine theoclate 25 mg tablets 30 tablet pack Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Avomine tablets. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist […]

Read more

Panadol Cold & Flu Plus Decongestant

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Panadol® Cold & Flu Plus Decongestant Paracetamol 500 mg and Phenylephrine Hydrochloride 5 mg Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PANADOL Cold & Flu Plus Decongestant. It does not contain all the available information.It does not take the […]

Read more

Zatamil

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZATAMIL* Consumer Medicine Information (CMI) summary The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Why am I using Zatamil? Zatamil contains the active ingredient mometasone furoate. Zatamil is used on the […]

Read more
1 2 3 15